Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study
{{output}}
Background and purpose: The treatment landscape for metastatic urothelial carcinoma (mUC) has rapidly evolved with immune checkpoint inhibitors (ICI), FGFR-targeted therapies, antibody-drug conjugates, and more recently first-lin... ...
